Search Results - "Seregin, Yuri"

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products by SCHWENGER, Vedat, MORATH, Christian, SALAVA, Alexander, AMANN, Kerstin, SEREGIN, Yuri, DEPPISCH, Reinhold, RITZ, Eberhard, BIERHAUS, Angelika, NAWROTH, Peter P, ZEIER, Martin

“…Peritoneal dialysis is limited by morphologic changes of the peritoneal membrane. Use of peritoneal dialysis fluids (PDF) that contain glucose degradation…”
Get full text

PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients by Dmitrieva-Zdorova, Elena V., Gabaeva, Marina V., Seregin, Yuri A., Bodoev, Nikolay V., Voronko, Olga E.

“…Objective: The programmed death-1 receptor, PD-1, is a negative regulator of T-cell activation. The PD-1.3 polymorphism of the PD-1 gene (PDCD1) has been…”
Get full text

Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling by Humpert, Per M, Djuric, Zdenka, Zeuge, Ulf, Oikonomou, Dimitrios, Seregin, Yuri, Laine, Klaus, Eckstein, Volker, Nawroth, Peter P, Bierhaus, Angelika

“…Endothelial progenitor cells (EPCs) have been shown to be involved in vascular regeneration and angiogenesis in experimental diabetes. Because insulin therapy…”
Get full text

Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography by Askretkov, A. D., Shatalov, D. O., Orlova, N. V., Zybin, D. I., Nikolaeva, V. V., Klishin, A. A., Tuzova, E. S., Minenkov, D. S., Kedik, S. A., Seregin, Yu. A.

“…Objectives. Polysorbate 80 (PS80) quantification in biopharmaceutical products has always been challenging owing to its minute content, absorption to the…”
Get full text

Quantification of polysorbate 80 in biopharmaceutical formulations implementing an optimized colorimetric approach by Seregin, A. S., Orlova, N. V., Askretkov, A. D., Zybin, D. I., Seregin, Yu. A.

“…Objectives . We hereby describe an improvement of a previously developed quantification technique for polysorbate 80 in biopharmaceutical formulations…”
Get full text

Development and validation of a method for the determination of the specific activity of recombinant monoclonal antibody eculizumab by Zybin, D. I., Seregin, A. S., Askretkov, A. D., Orlova, N. V., Seregin, Yu. A., Prostyakova, A. I., Kapustin, D. V.

“…Objectives. Developing reliable and accurate analytical methods is necessary for comparative pharmaceutical analysis using physicochemical, biological (in…”
Get full text

RAGE expression in the human peritoneal membrane by Kihm, Lars P., Wibisono, Dennis, Müller-Krebs, Sandra, Pfisterer, Friederike, Morath, Christian, Gross, Marie L., Morcos, Michael, Seregin, Yuri, Bierhaus, Angelika, Nawroth, Peter P., Zeier, Martin, Schwenger, Vedat

“…Background. Experimental animal models have demonstrated that the interaction of advanced glycation end-products (AGE) with their receptor RAGE is, at least in…”
Get full text